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ABSTRACT  
 
 
 
 
 The parasitic protist Trypanosoma cruzi is the causative agent of Chagas 
Disease. Chagas Disease causes greater than 15,000 deaths each year, and nearly 28 
million people are believed to be at risk of infection in Central and South America. 
This parasite has been described in many mammalian host species and has also 
been described in the United States. The purpose of this study was to attempt to use 
PCR to amplify T. cruzi-specific DNA directly from blood samples obtained from 
raccoons (Procyon lotor) trapped in Warren and Barren Counties of Kentucky in 
2007 and 2008.  DNA was successfully isolated from 487raccoon blood samples 
using a Qiagen QIAmp DNA Blood Mini Kit.  Each DNA sample was then subjected to 
PCR amplification using the T. cruzi specific primer pair known as TCZ1 and TCZ2. It 
was determined that T. cruzi DNA was present in 47% of raccoon blood samples 
with a 57% prevalence in Warren county and a 32% prevalence in Barren county.  
Groce (2008) estimated a similar overall prevalence of 38% in these same raccoons 
based upon the results of hemocultures established at the time of sample collection. 
 
Keywords: Trypanosoma cruzi, Chagas Disease, PCR, TCZ1, TCZ2,  Gel 
Electrophoresis. 
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 CHAPTER ONE 
INTRODUCTION 
Discovery of Chagas Disease: 
     While studying malaria in Brazil in 1909, Carlos Chagas was the first to discover 
the protozoan parasite, Trypanosoma cruzi (Chagas, 1909). Chagas noticed 
symptoms in the local Brazilian population that he could not attribute to malaria or 
to any other known disease. In his life, Chagas was able to determine not only the 
clinical symptoms of acute infection, but also the epidemiology and life cycle of the 
parasite within the vector and human host (Clayton, 2010 [A]). In honor of Carlos 
Chagas’ extensive work, the disease is now known as Chagas Disease.   
Chagas by the Numbers: 
Chagas disease has taken the lives of countless people due to heart failure 
and other cardiological and digestive system maladies.  The latest studies estimate 
that the disease causes approximately 12,500 to >15,000 deaths each year (Dias et 
al., 2008; Clayton, 2010 [A]).  In addition, approximately 10-12 million people are 
living today who are infected with T. cruzi (Clayton, 2010 [A]), many of whom have 
no idea they carry the parasite.  Studies have also shown that an estimated 28 
million people are at risk of contracting the disease from the insect vectors, blood-
sucking bugs in the family Reduviidae (Kirchhoff, 2003).  In rural areas, these
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triatome insects (commonly known as “kissing bugs”) reside in the cracks and 
crevices of palm trees, wood and rock piles, mud houses and livestock stables.  
The acute stage of infection with T. cruzi presents with very general 
symptoms: headache, fever, swollen lymph nodes (lymphadenopathy), enlargement 
of the liver and spleen (hepatosplenomegaly), and inflammation of cardiac tissue 
(myocarditis; CDC DPDx, 2011). One telling clinical sign that can occur is known as a 
chagoma. A chagoma is a localized swelling at the site where the parasites enter the 
body, and the swelling can last for several weeks before finally subsiding (Rassi et 
al. 2010).  When this chagoma is localized around the soft mucosa of the orbital 
region, it is referred to as Romaña’s sign. Romaña’s sign is the painless unilateral 
swelling of the periorbital area that occurs roughly 1 to 2 weeks after exposure 
(CDC DPDx, 2011).  However, the acute phase of Chagas disease is not always 
clinically apparent, and in some cases, acute symptoms don’t even surface at all. The 
disease can progress to an asymptomatic (or latent) phase for 30+ years before it 
presents again in the chronic phase with cardiac abnormalities, megaesophagus or 
megacolon, and ends most notably in congestive heart failure and death (Coura and 
Vinas, 2010).  Approximately 1/3 of patients who become infected with T. cruzi in 
endemic areas eventually develop the chronic manifestations of Chagas disease. 
Life cycle of T. cruzi: 
Triatome insects in the family Reduviidae are attracted to the CO2 exhaled by 
vertebrates, and the bugs take blood meals by biting near the mouth and nose of the 
host, usually while the host sleeps (Harder, 2004). As it takes a blood meal, the 
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triatome bug often times defecates. Metacyclic trypomastigote stages of T. cruzi are 
present in the bug’s feces, and it is this stage that is infective for the vertebrate host 
(CDC DPDx, 2011). The parasites enter broken skin (often at the site of the bite) or 
cross the soft mucosal tissues of the eyes, nose and lips (De Souza, 2002). Once inside 
the host, the trypomastigotes can enter into most types of tissue (Coura and Viñas, 
2010; Clayton, 2010). After entering a host cell, parasites transform into the 
amastigote life stage and begin multiplying rapidly by binary fission (CDC 2011, CDC 
DPDx 2011). The amastigote stages reside within the cytoplasm of the host cell until 
transforming back into trypomastigote stages, or until the host cell dies and bursts 
expelling the multitude of amastigotes contained inside. This cycle continues in 
many different tissues throughout the body, and can do so for many days before the 
host experiences clinically apparent symptoms (Coura and Viñas, 2010).  
The life cycle of the parasite continues when the host is again bitten by a 
“kissing bug”. The bug ingests infected blood of the host animal or human, and 
within the midgut of the triatome insect, trypomastigote stages transform into 
epimastigote stages and reproduce asexually to form more metacyclic 
trypomastigotes. These stages then migrate to the hindgut of the insect and wait for 
defecation to occur. Once the triatome insect takes another blood meal, it defecates 
and the cycle begins anew (CDC DPDx, 2011). In addition, oral infection can occur by 
consumption of food or beverages contaminated with feces from infected triatome 
bugs.  Recently, a total of 103 cases of Chagas disease were diagnosed in  
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Fig. 1- Summary of life cycle of Trypanosoma cruzi (CDC DPDx, 2011) 
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a school in Venezuela when children accidentally ingested contaminated guava juice 
(Clayton, 2010 [A]).  
In endemic areas of Central and South America, the risk of infection from 
blood donations, blood transfusions, and organ donations is also high. In 1960, 
patients receiving infected blood transfusions and organ donations in Brazil’s two 
largest cities acquired an estimated 16,000 cases of Chagas disease. The World 
Health Organization also estimated that roughly 7 million cases of Chagas were 
transmitted from infected blood and organs in the entire Latin American region in 
that same year (Coura and Viñas, 2010).  Although screening and public awareness 
have improved significantly in many Latin American countries, the risk of 
transfusion and organ donation acquired infection remains unacceptably high in the 
region (Clayton, 2010 [B]; Coura and Viñas, 2010). People from Latin America who 
carry the disease frequently immigrate to foreign countries potentially unaware of 
the infection they carry. This has vast international implications for many 
governments and health care systems that have never before experienced or known 
about this parasite. Couras and Viñas (2010) recently reported that there are 
>300,000 individuals infected with T. cruzi in the United States, >5,500 in Canada, 
>80,000 in Europe and in the western Pacific region, >3,000 in Japan and >1,500 in 
Australia.  With the world rapidly moving towards globalization, this raises the need 
for more education and screening for this parasitic infection worldwide.   
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Sylvatic cycle of T. cruzi in North America 
 Within the United States, the sylvatic cycle of infection with T. cruzi has been 
described and documented in the states of Alabama, California, Florida, Georgia, 
Louisiana, Maryland, Oklahoma, North Carolina, South Carolina, Tennessee, Texas, 
Virginia and Kentucky (McKeever et al., 1958; Olsen et al., 1964; John and Hoppe, 
1986; Karsten et al., 1992; Yabsley & Noblet, 2002; Dorn et al, 2007; Hancock et al, 
2005; Groce, 2008). The most recent study, conducted by Groce in 2008, reported a 
high prevalence of infection with T. cruzi in raccoons and opossums trapped in 
Warren and Barren Counties of south central Kentucky. Within the North American 
continent, T. cruzi has been identified in many mammalian hosts including raccoons 
(Procyon lotor), opossums (Didelphis virginiana), gray foxes (Urocyon 
cineroargenteus), striped skunks (Mephitis mephitis), macaques (Macaca silenus), 
lemurs (Lemur catta), woodrats (Neatoma magister), armadillos (Dasypus 
novemcincthus), bats (Eptiscus fuscus), moles (Neurotrichus gibbsii), and dogs (Canis 
familiaris) (Yabsley et al., 2001; James et al., 2002; Hall et al., 2007). Despite 
infecting a wide variety of mammalian hosts in North America, the incidence of 
human infection remains low, with only seven confirmed autochthonous cases 
occurring within the United States (Bern et al., 2007). The rate of infection within the 
United States is so low presumably due to better living conditions and different feeding 
habits of the Triatome vector. 
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Detection of T. cruzi: 
There have been several different methods employed to detect T. cruzi in 
samples of blood, including direct microscopy, xenodiagnosis, hemoculture, and 
polymerase chain reaction (PCR). The PCR method utilizes gene specific 
oligonucleotide primers that target a distinct gene sequence within a sample, and 
amplifies that gene sequence potentially hundreds of thousands of time. These 
thousands of copies of the DNA sequence (known as amplicons or PCR products) 
can then be visualized following agarose gel electrophoresis to determine the 
presence/absence of the target sequence within the sample. Studies have proven 
that PCR is far more sensitive than microscopic methods (Kirchhoff et al., 1996), 
especially when using the TCZ1 and TCZ2 primer pair (Moser et al., 1989).  The 
TCZ1 and TCZ2 primers are specific for a highly conserved 195-base pair (bp) 
repetitive nuclear sequence of T. cruzi (Moser et al., 1989).  The goal of the present 
study was to attempt to use PCR to amplify T. cruzi-specific DNA directly from blood 
samples obtained from raccoons (Procyon lotor) trapped in Warren and Barren 
Counties of Kentucky in 2007 and 2008.  We hypothesize that PCR analysis will 
allow for a more accurate determination of the prevalence of T. cruzi infection in 
raccoons than the hemoculture method previously employed by Groce in 2008. 
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CHAPTER 2 
MATERIALS AND METHODS 
DNA Extraction:  
     200 μL of whole, non-coagulated blood samples stored at 4oC from 47 raccoon 
specimens were used in this study. DNA was extracted using the Qiagen QIAamp® 
DNA blood mini kit, according to the manufacturer’s recommended protocol. 
Afterwards, DNA concentration was determined using a Thermo Nanodrop ND-100 
spectrophotometer. Purified DNA samples were stored at -20oC until use.  
PCR Amplification:  
     PCR amplification was performed on each DNA sample, using the TCZ1 and TCZ2 
primer set. The TCZ1 and TCZ2 primer pair was designed to amplify 188 bp of a 
195-bp repetitive nuclear sequence of T. cruzi (Moser et al., 1989). The TCZ1 and 
TCZ2 primers consisted of the following nucleotide sequences: TCZ1 (5’-CGA GCT 
CTT GCC CAC ACG GGT GCT 3’) TCZ2 (5’-CCT CCA AGC AGC GGA TAG TTC 
AGG 3’).  For each PCR analysis, a 50µl reaction was set up containing 20µl 2.5X 
Master Mix (5 Prime, Gaithersburg, MD), 1 µl (4µM) of each primer, a standardized 
amount of template DNA, and sterile nanopure water to bring the total volume to 50 
µl. A negative control containing sterile nanopure water in place of template DNA 
was included with each analysis. Two positive controls using template DNA 
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prepared from T. cruzi type I and type IIa reference strains were also included.  
Reaction mixtures were loaded into an automated DNA thermal cycler to undergo 
amplification according to the protocol outlined in Table 1. The TCZ1 and TCZ2 
primers are highly specific for T. cruzi-DNA, and should not amplify other DNA that 
is found within the blood samples (i.e. raccoon leukocyte DNA). 
 
 
Table 1. Thermocycler Protocol used for TCZ1 and TCZ2 primers. 
Steps Temperature (°C) Time  # of cycles 
Initial Denature   94 2 min 1 
Denature   94 1 min 30 
Annealing   64.5 30 sec   
Extension   72 15 sec   
Final extension   72 5 min 1 
Hold   4 Indefinite 1 
  
 
Agarose Gel Electrophoresis:  
 Once all of the samples had been subjected to the PCR procedure, a 2 μL 
sample of the resulting PCR products were stained with a phosphorescent dye and 
loaded onto 3% agarose gels and subjected to electrophoresis at 80V for 2 hours to 
separate the amplified DNA fragments. The resulting gels were imaged using a 
Fluorochem HD2 ultraviolet imager. A 50bp DNA ladder was employed to allow an 
estimate of the length of our target DNA sequence. Additionally, the PCR procedure 
was repeated on all samples, to confirm results.  
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After gels were analyzed and the positive and negative samples were 
determined, results were compared to the 2008 study performed by Groce, to 
determine how PCR analysis performed in comparison to hemoculture.
11 
 
CHAPTER 3 
RESULTS 
     After total DNA was isolated from each blood sample using the Qiagen QIAamp® 
DNA blood mini kit, DNA concentrations were measured using a Nanodrop ND-1000 
spectrophotometer.  Concentrations ranged from 8.6 ng/μL to 210.9 ng/μL, with an 
average concentration of between 30 and 50 ng/μL. These values are shown in 
Tables 1 and 2 below.  
Following PCR amplification of all DNA samples, products were analyzed by 
agarose gel electrophoresis. Twenty-two out of 47 DNA samples were judged to be 
PCR positive for T. cruzi DNA based on the presence of a 188 bp band visible in the 
gel with UV illumination. The results of PCR analysis on Warren County raccoon 
DNA samples are shown in Figures 2a and 2b and the results of PCR analysis on 
Barren County raccoon DNA samples are shown in Figure 3.  Results are also 
summarized in Tables 2 and 3. 
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200 BP 
 
 
 
 
Figure 2A. PCR products resulting from amplification of raccoon DNA (RW series; part 
I) with primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3% gel). 
 
 
Figure 2B.  PCR products resulting from amplification of raccoon DNA (RW series; part 
II) with primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3% gel). 
 
 
Figure 3.  PCR products resulting from amplification of raccoon DNA (RB series) with 
primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3%
 
Gel electrophoresis was repeated on the samples that were faintly positive or 
samples that were judged to be positive by hemoculture or by prior PCR analysis.  
The results of this second electrophoretic analysis can be seen in Figure 4.  
Hemoculture results versus PCR positi
there were 7 additional 
hemoculture negative in our data, and 
showed positive results
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 gel)
ve samples are shown in Tables 4 and 5
positive samples in which the sample was PCR positive and 
3 discrepancies where the hemoculture 
 and the PCR negative. 
 
 
. In all, 
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Tables 2 and 3: Sample number, concentration, and presence of T. cruzi DNA 
for Warren and Barren counties, respectively. 
 
 
 
 
 
 
 
Sample Number 
(Warren Series) 
DNA Concentration 
(ng/μL) 
Presence of T. 
cruzi DNA? 
RW1 67.4 + 
RW2 33.3 + 
RW3 17.5 - 
RW4 34.6 - 
RW5 53.9 + 
RW6 36.5 - 
RW7 31.2 + 
RW8 33.6 - 
RW9 12.9 - 
RW10 35.5 + 
RW11 78.7 + 
RW12 8.6 - 
RW13 155.3 + 
RW14 110.7 + 
RW15 29.3 + 
RW16 32.7 + 
RW17 30.3 - 
RW18 28.2 - 
RW19 32.4 - 
RW20 33.6 + 
RW21 42.7 - 
RW22 36.7 + 
RW23 28.7 + 
RW24 28.7 + 
RW26 77.7 - 
RW27 45.1 + 
RW28 38.2 + 
RW29 48.4 - 
Sample Number 
(Barren Series) 
DNA Concentration 
(ng/μL) 
Presence of T. 
cruzi DNA? 
RB1 21.0 - 
RB2 14.4 - 
RB3 10.0 - 
RB8 12.0 + 
RB9 44.3 - 
RB10 45.4 - 
RB11 32.6 + 
RB12 17.5 + 
RB13 210.9 - 
RB14 32.7 + 
RB15 14.7 - 
RB16 21.3 - 
RB17 35.3 - 
RB18 46.1 - 
RB19 40.8 + 
RB20 38.4 - 
RB21 42.4 - 
RB22 31.4 + 
RB23 66.5 - 
15 
 
 
Figure 4.  PCR products resulting from amplification of selected raccoon DNA samples 
from the RW and RB series with primers TCZ1 and TCZ2 followed by agarose gel 
electrophoresis (3% gel). 
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Tables 4 and 5: The 2008 Hemoculture versus present PCR data for the Warren and 
Barren county samples, respectively.  Note: The light gray shading denotes a 
negative (-) hemoculture result and a positive (+) PCR result. The dark gray shading 
denotes a positive (+) hemoculture result and a negative (-) PCR result.  
 
 
 
 
 
 
Sample Hemoculture 
PCR 
results 
RB1 - - 
RB2 - - 
RB3 - - 
RB8 - + 
RB9 - - 
RB10 - - 
RB11 + + 
RB12 + + 
RB13 - - 
RB14 + + 
RB15 - - 
RB16 - - 
RB17 - - 
RB18 - - 
RB19 - + 
RB20 - - 
RB21 - - 
RB22 - + 
RB23 - - 
Sample Hemoculture 
PCR 
Results 
RW1 - + 
RW2 + + 
RW3 - - 
RW4 - - 
RW5 + + 
RW6 - - 
RW7 + + 
RW8 - - 
RW9 + - 
RW10 + + 
RW11 + + 
RW12 - - 
RW13 + + 
RW14 + + 
RW15 + + 
RW16 - + 
RW17 - - 
RW18 + - 
RW19 - - 
RW20 + + 
RW21 + - 
RW22 + + 
RW23 - + 
RW24 + + 
RW26 - - 
RW27 + + 
RW28 - + 
RW29 - - 
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CHAPTER 4 
DISCUSSION 
The results of the present study confirm a high prevalence of T. cruzi 
infection in raccoon populations in Warren and Barren counties of Kentucky. Direct 
PCR amplification of raccoon blood samples using the highly sensitive T. cruzi-
specific primers TCZ1 and TCZ2 revealed that 57% (16/28) of Warren county 
raccoons were positive for T. cruzi DNA and 32% (6/19) of raccoon blood samples 
from Barren County were positive.  A total of 22 out of 47 raccoons in this study 
were judged to contain T. cruzi DNA, giving an overall prevalence of 47% for the 
region. 
 A variety of studies have been performed to determine the prevalence of T. 
cruzi in raccoon populations in various regions of the United States over the past 
several decades. The prevalence of infection reported in these studies ranged from a 
low of 1.5% reported by Mckeever and coworkers in Georgia and Florida in 1958 
(Mckeever et al., 1958) to a high of 63% reported in a study performed by John and 
Hoppe in Oklahoma in 1986.  However, the John and Hoppe study did have a very 
small sample size with only 8 raccoon samples collected (John and Hoppe, 1986). 
Since many of these studies have been performed, the scientific community has seen 
the advent of newer and more sensitive diagnostic methods such as hemoculture, 
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indirect immunofluorescence assay (IFAT), enzyme-linked immunosorbent assay 
(ELISA) and PCR which have made testing for the parasite much more efficient and 
sensitive than the archaic methods of direct visual microscopy and xenodiagnosis.  
 Every method of parasite detection that has been developed has its 
advantages and disadvantages, yet PCR is widely viewed as one of the most sensitive 
and effective procedures currently available.  Visual microscopy of blood smears or 
tissue mounts is the most direct method of identification, however, microscopy has 
its disadvantages because the blood or tissues biopsied may not contain the 
parasites, the blood and tissues must be fresh in order to preserve the parasite for 
identification, and this method is time consuming and does not allow for as many 
samples to be processed daily. In contrast, PCR can amplify incredibly small 
amounts of DNA within a sample, it can be performed on an older sample (as 
demonstrated by this study), and large numbers of samples can be analyzed 
simultaneously.  PCR also has been shown to be significantly more effective at T. 
cruzi identification than direct microscopy (Pizarro et al. 2007).  The technique 
known as xenodiagnosis is a longstanding indirect method of detecting T. cruzi, 
however xenodiagnosis can also fail since the triatome insects do not always ingest 
the parasite, and the parasite may not always proliferate within the gut as expected. 
This technique also requires the labor-intensive maintenance of large quantities of 
triatome bugs in the laboratory.  Hemoculture requires blood samples to be 
introduced into culture medium under sterile conditions, with hopes that the 
parasite will eventually grow and be identified.  However, as with other methods, 
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the samples must be fresh and free of bacterial contamination, and the parasites 
may not grow as expected. Finally, IFAT is also an effective method of diagnosis, but 
it too can be inaccurate because it relies on the immunological response of the host 
(raccoon, human). The IFAT can give a false negative result if for some reason the 
host is immunologically compromised or if the blood sample is taken too early in the 
infection process.  The PCR technique is much more effective because it tests 
directly for the presence of the parasitic DNA within the sample. It also doesn’t 
depend upon the immune response of the host (as with IFAT), or the time 
consuming process of in vitro cultivation under sterile conditions (hemoculture).  
The PCR technique does depend upon the effectiveness of the chosen primers and 
the quality of the DNA samples, but if these conditions are met, PCR can be 
extremely specific and sensitive. 
 The TCZ1 and TCZ2 primers used in this study were carefully chosen for 
those exact reasons.  The TCZ primer pair recognizes a highly repetitive, non-coding, 
nuclear sequence within the T. cruzi genome (Moser et al., 1989; Kirchhoff et al., 
1996).  Due to the highly repetitive nature of this sequence within the genome, 
amplification occurs at a much higher rate than if the primers were recognizing just 
one region of DNA. The TCZ1 and TCZ2 primers are also highly specific and can only 
recognize the target DNA sequence and not any other DNA present in the sample. 
The selection of the TCZ1 and TCZ2 primers for this study was based upon a careful 
review of the literature. Many other studies have shown these primers to be 
effective in various situations including identification in insect vectors and reservoir 
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hosts (McKeever et al., 1958; Olsen et al., 1964; John and Hoppe, 1986; Karsten et al., 
1992; Yabsley & Noblet, 2002; Dorn et al, 2007; Hancock et al, 2005; Groce, 2008, 
Yabsley et al, 2001; Hall et al, 2007) and in patients with Chagas disease (Avila et al., 
1993; Dorn et al., 2007; Bern et al., 2007;G. Russomando, et al. 1992; G. Russomando 
et al. 1998; Leiby, et al. 2000; Maldonado et al., 2004; Carriazo et al., 1998; Marcon 
et al., 2011). There have also been studies performed on very old or archived 
specimens where it was shown that PCR was still effective in detecting T. cruzi long 
after any other method would have been unusable (James et al., 2002; Williams et 
al., 2009).  For example, TCZ1 and TCZ2 primers were used in a 7 years post-
mortem patient to determine the exact cause of death by Chagas disease (Ochs et al., 
1996).  Studies designed to compare the TCZ 1 and 2 primers with other primer sets 
have shown that the TCZ series is by far the most sensitive. In a 2005 study, Virreria 
and co-workers tested the TCZ1/TCZ2 primers against nuclear DNA primers 
BP1/BP2, O1/O2, Pon1/Pon2, and Tca1/Tca2 and kinetoplast DNA primers 
S35'/S36' and 121/122 and showed that TCZ1/TCZ2 primers were the most 
sensitive (Virreria et al., 2005). A study in 2006 by Trejo tested the TCZ series 
against the kinetoplast DNA primers S35'/S36' and 121/122 and reported the same 
findings (Trejo, 2006). 
 When the PCR results obtained in the present study were compared to the 
hemoculture results obtained by Groce in 2008, several discrepancies were 
observed. As seen in Tables 4 and 5, there were 7 samples that were originally 
hemoculture negative, but were determined to be PCR positive in this study (RW1, 
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RW16, RW23, RW28, RB8, RB19, and RB22).  In addition, there were 3 samples that 
were hemoculture positive and PCR negative in the present study (RW9, RW18, 
RW21).  In the cases where this study showed the RW1, RW16, RW23, RW28, RB8, 
RB19, and RB22 blood samples to be T. cruzi positive, we can assume that PCR was 
the more sensitive of the two methods in detecting the presence of the parasite. 
However, in three cases  (RW9, RW18, and RW21) it would appear that hemoculture 
was more sensitive than PCR. One factor to consider when interpreting these results 
is the age of the blood samples at the time of DNA isolation. When this study first 
began in 2009, the raccoon blood samples had been stored at 4°C for over a year. 
Many investigators have confirmed that PCR can still be effective even years after 
samples would be considered to be non viable (James et al., 2002; Williams et al., 
2009; Ochs et al., 1996).  However, it seems reasonable to predict that the integrity 
of the DNA present in the raccoon blood samples would decrease with extended 
storage at 4oC. The only way this could have been avoided would have been to 
isolate DNA from the blood samples very soon after the raccoons had been trapped. 
What can be understood is that in the case of future studies for T. cruzi prevalence, 
multiple detection methods should be employed to get the most accurate results. 
 In conclusion, PCR has confirmed a high prevalence of T. cruzi infection in the 
raccoon populations of Warren and Barren counties in south central Kentucky. Our 
results demonstrate that PCR with the TCZ1 and TCZ2 primer pair can be a very 
effective method for detecting T. cruzi DNA in raccoon blood samples even after 
long-term storage at 4oC.  However, to achieve the most accurate estimate of 
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parasite prevalence in wild mammal populations it is recommended that 
investigators use a combination of both hemoculture and PCR analysis.  
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